Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tafluprost-timolol fixed combination in glaucoma or ocular hypertension
NCT05299593Phase 4Unknown
- Sponsor
- Fondazione G.B. Bietti-IRCCS
- Start
- Jun 2020
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of tafluprost, timolol in Open-angle glaucoma (OAG), ocular hypertension, sponsored by Fondazione G.B. Bietti-IRCCS. Status: unknown.
02
Drugs
tafluprosttimolol
03
Conditions
Open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT05299593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05299593.